Literature DB >> 3068107

Medicaid patients' access to new drugs.

H Grabowski.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3068107     DOI： 10.1377/hlthaff.7.5.102

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN： 0278-2715            Impact factor:   6.301


× No keyword cloud information.
  4 in total

Review 1.  Economic impact of cost-containment strategies in third party programmes in the US. Part II.

Authors:  C M Kozma; R M Schulz; W M Dickson; J T Dye; E R Cox; D A Holdford; L Michael; W N Yates; T L Young
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

2.  Impact of consumer fees on drug utilisation.

Authors:  D G Smith; D M Kirking
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

3.  Pharmaceutical formulation and healthcare expenditures.

Authors:  D A Sclar; T L Skaer
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

4.  The effect of Medicaid formularies on the availability of new drugs.

Authors:  H G Grabowski; S O Schweitzer; S R Shiota
Journal:  Pharmacoeconomics       Date:  1992       Impact factor: 4.981
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.